Charles River Laboratories
251 Ballardvale Street
Wilmington
Massachusetts
01887
United States
Tel: 877-274-8371
Website: http://www.criver.com/
About Charles River Laboratories
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.
For more information, please visit www.criver.com.
Equal Employment Opportunity
Charles River Laboratories, Inc. is an Equal Opportunity Employer M/F/Disabled/Vet
418 articles with Charles River Laboratories
-
Charles River Laboratories (Massachusetts) To Offer $300 Million Convertible Senior Notes
6/6/2006
-
Charles River Laboratories (Massachusetts) And genOway Announce A North American Strategic Alliance Enabling Genetically-Modified Research Models To Assist The Drug Discovery Process
5/16/2006
-
Charles River Laboratories (Massachusetts) To Present At Bank of America Health Care Conference
5/15/2006
-
Kendle International Invites You To Attend An Investor Conference Call And Webcast To Discuss Its Acquisition Of The Phase II-IV Clinical Services Business Of Charles River Laboratories International, Inc.
5/10/2006
-
Kendle International Announces Acquisition Of Phase II-IV Clinical Services Business Of Charles River Laboratories International, Inc.
5/10/2006
-
Charles River Laboratories (Massachusetts) Announces First-Quarter 2006 Results
5/10/2006
-
Charles River Laboratories Implements BioTrove, Inc. High-Throughput SNP Genotyping System
4/18/2006
-
Charles River Laboratories Schedules First-Quarter 2006 Earnings Release And Conference Call
4/12/2006
-
Charles River Laboratories Appoints Nicholas Ventresca As Corporate Senior Vice President, Information Technology, And Chief Information Officer
3/26/2006
-
Charles River Laboratories To Present At SG Cowen & Co., LLC Health Care Conference
3/6/2006
-
Charles River Laboratories To Present At UBS Healthcare Services Conference
2/10/2006
-
Charles River Laboratories Announces Fourth-Quarter And Full-Year 2005 Results
2/9/2006
-
Charles River Laboratories Appoints John C. Ho, M.D. As Senior Vice President, Corporate Strategy
1/16/2006
-
Charles River Laboratories Becomes Deltagen's Exclusive, Worldwide Custodian, Supplier Of Knockout Mice Repository
1/9/2006
-
Charles River Laboratories To Present At JPMorgan Healthcare Conference
1/6/2006
-
Charles River Laboratories Provides Guidance For 2006 And Reaffirms Guidance For 2005
12/14/2005
-
Charles River Laboratories Announces Third-Quarter 2005 Results
10/28/2005
-
Charles River Laboratories Montreal Utilizes Vivometrics, Inc. LifeShirt In Groundbreaking Non-Invasive, Ambulatory, Respiratory And ECG Preclinical Studies
10/24/2005